Overexpression of CD44 Accompanies Acquired Tamoxifen Resistance in McF7 Cells and Augments Their Sensitivity to the Stromal Factors, Heregulin and Hyaluronan

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-12-458
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

The Hyaluronan Receptor (CD44) Participates in the Uptake and Degradation of Hyaluronan

Journal of Cell Biology
MedicineCell Biology
1992English

Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Hyaluronan-Cd44 Interactions Mediate Contractility and Migration in Periodontal Ligament Cells

Cell Adhesion and Migration
Molecular NeuroscienceCell BiologyCellular
2019English

Hyaluronan–CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression

Advances in Cancer Research
Cancer ResearchOncology
2014English

Heregulin Β1 Drives Gefitinib-Resistant Growth and Invasion in Tamoxifen-Resistant McF-7 Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2007English

Induced Overexpression of CD44 Associated With Resistance to Apoptosis on DNA Damage Response in Human Head and Neck Squamous Cell Carcinoma Cells

International Journal of Oncology
Cancer ResearchOncology
2016English

Increased Invasion and Tumorigenicity Capacity of CD44+/CD24- Breast Cancer McF7 Cells in Vitro and in Nude Mice

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

Oxidative Stress Contributes to the Tamoxifen-Induced Killing of Breast Cancer Cells: Implications for Tamoxifen Therapy and Resistance

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy